|
Home >> Health >> Pharmacy >> Drugs and Medications >> Z >> Zafirlukast |
|
Zafirlukast is an unwritten leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma. Available as a tablet, it bars a action of leukotriene C4 on its receptors, so reducing constriction of the airways, build-higher of mucous secretion in the lungs & inflammation of the eupneic passages. Zafirlukast is marketed by AstraZeneca with the marque Accolate, Accoleit, & Vanticon. It was a number 1 LTRA to become marketed within a United states & is at present sanctioned in terminated Lx countries, including the UK, Japan, Italy, Spain, Canada, Brazil & China.
| |
|
Zafirlukast Information from the RxList. MedlinePlus: Zafirlukast Features information about dosage, usage, warnings, and side effects. Accolate (Zafirlukast) Information from DrugDigest on dosage, usage, side effects, and interactions. Accolate - AstraZeneca Official pharmaceutical website for Accolate (zafirlukast), a nonsteroidal tablet for the prevention and continuous treatment of asthma in adults and children 5 years of age and older; available only by prescription. Accolate Prescribing information for US residents in PDF format.[Acrobat Reader required] |
© 2005 GeneralAnswers.org